Condition | Model | Cell source | Administration route | Results | Ref |
---|---|---|---|---|---|
AD | Mice | BM | Intranasal | Stimulation of neuroprotection in part through inhibition of neuroinflammation | [99] |
AD | Mice | BM | Intravenous | Attenuation of Aβ levels and provoking anti-inflammatory impact leading to the amelioration of learning and memory functions | [261] |
AD | Mice | BM | Intravenous | Reducing cognitive deficits through exosomal miR-146a | [262] |
AD | Rat | BM | Intravenous | Induction of neurogenesis | [263] |
MS | Mice | PDL | Intravenous | Inhibition of NLRP3 inflammasome activation | [189] |
MS | Mice | BM | Intravenous | Attenuation of demyelination lesion area and reducing diseases severity | [186] |
MS | Mice | BM | Intravenous | Triggering remyelination and attenuation of the neuroinflammation | [198] |
MS | Mice | BM | Intravenous | Reducing diseases severity by HGF delivery | [201] |
MS | Mice | AT | Intravenous | Improving the Tregs population and IL-4 levels | [264] |
MS | Mice | PDL | Intravenous | Improving IL-37 expression causing down-regulation of the pro-inflammatory cytokines levels | [265] |
MS | Mice | SHEDs | Intravenous | Attenuation of demyelination and axonal injury, inhibition of inflammatory cell infiltration and also promoting M2/M1 macrophage ratio | [266] |
PD | Rat | BM | Intravenous | Reducing the deterioration of DA neuron in SN and thus promoting dopamine levels in striatum | [100] |
PD | Rat | BM | Intravenous | Induction of the protective effect on DA neuron | [101] |
PD | Mice | AT | Intravenous | Mitigation of autophagy and pyroptosis | [233] |
PD | Mice | AT | Intraperitoneal | Eliciting the HBMECs angiogenesis | [102] |
PD | Rat | AT | Intravenous | Exerting antioxidant effects by improving sirtuin 3 levels | [267] |
PD | Rat | BM | Intravenous | Amelioration of motor activities | [268] |
PD | Rat | BM | Intranigral Intrastriatal | Promoting neural plasticity | [269] |
PD | C. elegans | BM | NA | Decreasing α-syn aggregates in striatum | [228] |
HD | Mice | AM | Intraperitoneal | Amelioration of motor functions | [270] |
ALS | Mice | AT | Intravenous Intranasal | Down-regulation of glial cells function, favoring motor neurons, and eliciting protective effect on neuromuscular junctions (NMJs) | [271] |